Extract
Phase Forward Unveils CRO Partner Program; CRO Advantage Program, Tailored for CROs of All Market Segments and Adoption Models, Provides Flexibility.
PHILADELPHIA -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its CRO Advantage Program based on its successful existing relationships with leading contract research organizations (CROs). The formal partner program is designed specifically to meet the needs of CROs...
See the full content of this document
Sponsored links
